• Type of Event: Q1 FY27 Earnings Conference Call hosted by ICICI Securities to discuss Unaudited Financial Results for quarter ended June 30, 2026 and business outlook.
  • Date and Time: The conference call was held on Wednesday, August 12, 2026. Specific time and time zone were not mentioned in the transcript.
  • Purpose: Discussion of quarterly results, operating environment, segment performance, margin pressures, and strategic priorities for FY27.
  • Management Participants: Ms. M. R. Jyothy (Chairperson and Managing Director) and Mr. Pawan Agarwal (Chief Financial Officer). The call was moderated by Mr. Aniket Kamble from ICICI Securities.
  • Availability of Materials: The financial results and investor presentation were available on the company website (www.jyothylabs.com) and stock exchanges. The transcript was filed with exchanges on August 14, 2026.
  • Compliance Statement: The document contains standard regulatory filing language but does not explicitly state that no unpublished price sensitive information (UPSI) was shared.

Financial and Business Highlights

Financial Performance Q1 FY27:

  • Revenue growth (ex-Pril and FA): 8.1% in value terms, 5.3% in volume terms YoY
  • Gross margin: 38.5% (down 950 basis points YoY)
  • Employee cost: 11.4% of revenue (vs 11.5% YoY)
  • A&P spend: 6.5% of revenue (vs 10.8% YoY)
  • Other expenses: 12.2% of revenue (vs 12.1% YoY)
  • EBITDA margin: 8.4% (down approximately 820 basis points YoY)
  • Net cash balance: ~INR 850 crores

Segment Realignment: From Q1 FY27, the company reports under three segments:

1. Fabric Care: 14% value growth, 10% volume growth in Q1

2. Home Care: 2.4% growth YoY (ex-Pril sales)

3. Personal Care: Performance remained subdued during the quarter

Operational Updates:

  • Fabric Care maintained strong momentum with detergent powders and bars growing in double digits
  • Home Care impacted by Pril exit effective May 31, 2026
  • Newly launched bioenzyme-based Exo Liquid showing encouraging progress
  • Exo franchise (bars, powders, liquids, scrubbers) grew mid- to high single-digits in value, double digit in volume
  • Household insecticides affected by extended summer and delayed rainfall
  • Launched Maxo incense sticks in July 2026 as government-approved solution
  • Personal Care impacted by price increases and transient supply chain disruptions

Guidance and Outlook:

  • FY27 revenue growth expectation: Double-digit (excluding Pril business)
  • EBITDA margins likely to remain under pressure during FY27 due to elevated crude-linked input costs
  • H2 FY27 expected to be substantially better than H1 subject to demand momentum and commodity price stability
  • Margin recovery expected to be progressive and closely linked to top line growth

Strategic Priorities for FY27:

  • Scale recent new product developments (NPDs)
  • Maintain strong innovation pipeline
  • Improve general trade productivity
  • Sustain volume growth despite price increases
  • Invest in brands in calibrated manner
  • Focus on cost optimization, supply chain efficiencies, procurement excellence, and value engineering

Additional Notes Section

  • The document is a regulatory filing containing the transcript of the earnings conference call held on August 12, 2026.
  • The transcript includes detailed Q&A session with analysts from IIFL Capital, Buglerock PMS, ASK Investment Managers, Prescient Capital, Equirus Securities, Green Capital Single Family Office, and individual investors.
  • Key discussion topics included: pricing strategy (blended 4-4.5% price increase with 3% flowing through Q1), competitive intensity, margin recovery trajectory, channel performance (modern trade and e-commerce growing 25-30%), working capital management, royalty payments, M&A strategy, and new product development.
  • The company emphasized its 90% exposure to crude-linked inputs in Fabric Care and Home Care segments as the primary reason for margin pressure.
  • Management expressed confidence in long-term margin recovery through diversification away from crude dependency, innovation, and product portfolio expansion.
  • No financial data beyond what was disclosed in the results was shared during the call.